$100K - $500K

ArcaScience is the #1 startup for predicting a drug's potential with 4 LLMs, saving $180 million to our clients (Sanofi, Takeda, Pfizer) in 2023 with $10k ARR end 2023, $500k worth of new contract jan. 2024. Customers are blue chip pharma & biotechs. ArcaScience has been awarded multiple times for its groundbreaking AIs. Competitors include - IQVIA ; Scibite ; Deloitte ArcaScience has currently 2 options : either being bought out, or raising funds. We currently have a lead fund and could be finishing the round in the coming month. The funds are commited and we are going through final discussions. The valuation of the company approved in the Term Sheet is $7.5 million post-money. Upon noticing the surge in research in AI, it seemed to be a good opportunity to seek companies that could synergies with ArcaScience and bring our groundbreaking technology to a whole new level, through acquisition. This asking price is therefore based on the negociation led during the fundraising, minus the effort needed to integrate our 4 LLMs.

Request Access

To View Profile

Request Access To Private Information